144 related articles for article (PubMed ID: 11446102)
1. Recombinant vaccine technology in veterinary medicine.
Van Kampen KR
Vet Clin North Am Small Anim Pract; 2001 May; 31(3):535-8, vii. PubMed ID: 11446102
[TBL] [Abstract][Full Text] [Related]
2. Vaccines in veterinary medicine: a brief review of history and technology.
McVey S; Shi J
Vet Clin North Am Small Anim Pract; 2010 May; 40(3):381-92. PubMed ID: 20471523
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in veterinary vaccinology.
Shams H
Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
[TBL] [Abstract][Full Text] [Related]
5. [DNA vaccines for veterinary medicine].
Gerdts V; Mettenleiter TC
Dtsch Tierarztl Wochenschr; 2001 Jan; 108(1):3-10. PubMed ID: 11232422
[TBL] [Abstract][Full Text] [Related]
6. Genomics and vaccine development.
Gay CG; Zuerner R; Bannantine JP; Lillehoj HS; Zhu JJ; Green R; Pastoret PP
Rev Sci Tech; 2007 Apr; 26(1):49-67. PubMed ID: 17633293
[TBL] [Abstract][Full Text] [Related]
7. Applications of pox virus vectors to vaccination: an update.
Paoletti E
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11349-53. PubMed ID: 8876138
[TBL] [Abstract][Full Text] [Related]
8. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
Pardo MC; Bauman JE; Mackowiak M
Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
[TBL] [Abstract][Full Text] [Related]
9. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
Kim SH; Samal SK
Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
[TBL] [Abstract][Full Text] [Related]
10. Conclusions--future trends in veterinary vaccinology.
Pastoret PP; Schudel AA; Lombard M
Rev Sci Tech; 2007 Aug; 26(2):489-94, 495-501, 503-9. PubMed ID: 17892169
[No Abstract] [Full Text] [Related]
11. [Gene technology and veterinary medicine. II. Vaccines produced by genetic technics and analysis of highly variable DNA segments].
Hübscher U
Schweiz Arch Tierheilkd; 1987 Nov; 129(11):553-64. PubMed ID: 3324336
[No Abstract] [Full Text] [Related]
12. Experience with veterinary vaccines in warm climates.
Tulasne JJ; Lefèvre PC; Blancou J
Dev Biol Stand; 1996; 87():33-42. PubMed ID: 8854000
[TBL] [Abstract][Full Text] [Related]
13. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
14. Animal vaccination and the veterinary pharmaceutical industry.
O'Brien D; Zanker S
Rev Sci Tech; 2007 Aug; 26(2):471-7. PubMed ID: 17892167
[TBL] [Abstract][Full Text] [Related]
15. 100 volumes of Preventive Veterinary Medicine--The past, the present and the future.
Salman MD; Doherr MG; Erb HN; Frankena K; Gardner IA; Stegeman JA; Stryhn H; Ward MP; Weigel R
Prev Vet Med; 2011 Jun; 100(1):1-3. PubMed ID: 21513994
[No Abstract] [Full Text] [Related]
16. Perspective on veterinary preventive medicine in the United States.
Hubbert WT
J Am Vet Med Assoc; 1979 Feb; 174(4):378-9. PubMed ID: 447563
[No Abstract] [Full Text] [Related]
17. Regulatory requirements for vaccine authorisation.
Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
[TBL] [Abstract][Full Text] [Related]
18. [The use of genetic engineering in veterinary medicine with examples from epidemiology, diagnosis and drug production].
Mayr A; Hübert P
Tierarztl Prax; 1990 Apr; 18(2):99-108. PubMed ID: 2112273
[TBL] [Abstract][Full Text] [Related]
19. Changing environments and external factors that may impact veterinary medicine.
Pritchard W
J Am Vet Med Assoc; 1989 May; 194(10):1394-5, 1399. PubMed ID: 2722630
[No Abstract] [Full Text] [Related]
20. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
